Literature DB >> 25973092

Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.

Gönül Gurol1, Ihsan Hakkı Ciftci2, Halil Harman3, Engin Karakece2, Ayhan Kamanli3, Ibrahim Tekeoglu3.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disorder that affects approximately 1% of the world's population. The pathogenesis of RA is not understood fully. It is assumed that endothelial function is associated with the proinflammatory state of RA. Endothelial dysfunction/activation reflects the increased level of von Willebrand factor (vWF) and a shift toward prothrombotic activity of the endothelium. The present study was performed to investigate the possible relationships between vWF and claudin-5 and the level of disease activity in patients with RA. The study population was divided into four groups according to the disease activity score in 28 joints (DAS28): remission group (RG), 18 patients (DAS28 < 2.6); low disease activity group (LDAG), 23 patients (DAS28 > 2.6-3.2); moderate disease activity (MDAG), 23 patients (DAS28 > 3.2-5.1); high disease activity group (HDAG), 14 patients (DAS28 > 5.1); and control group (CG), 10 healthy subjects. Claudin-5 and vWF assessment were derived from serum samples gathered from the patients known to have RF and anti-CCP titers in the normal ranges. A high positive association of claudin-5 and vWF with the MDAG was observed (P < 0.001). The results of our study indicated that the relationship between vWF and claudin-5, which are indicators of endothelial cell dysfunction and tight junction activity, may be a predictor of disease activity. Further studies are required to investigate these pathways to shed light on the roles of claudin-5 and vWF in the progression of inflammation and other vascular conditions.

Entities:  

Keywords:  Claudin-5; rheumatoid arthritis; von Willebrand factor (vWF)

Mesh:

Substances:

Year:  2015        PMID: 25973092      PMCID: PMC4396339     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta.

Authors:  Malgorzata Burek; Katrin Steinberg; Carola Y Förster
Journal:  Mol Cell Endocrinol       Date:  2014-05-15       Impact factor: 4.102

2.  [Clinical associations of C-reactive protein in systemic sclerosis].

Authors:  R T Alekperov; A A Baranov; N E Abaĭtova
Journal:  Ter Arkh       Date:  2006       Impact factor: 0.467

3.  Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.

Authors:  Aino Soro-Paavonen; Wei-Zeng Zhang; Kylie Venardos; Melinda T Coughlan; Emma Harris; David C K Tong; Daniella Brasacchio; Karri Paavonen; Jaye Chin-Dusting; Mark E Cooper; David Kaye; Merlin C Thomas; Josephine M Forbes
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

Review 4.  Angiogenesis and vasculogenesis in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Timea Besenyei; Agnes Szentpétery; Alisa E Koch
Journal:  Curr Opin Rheumatol       Date:  2010-05       Impact factor: 5.006

Review 5.  Unwinding the von Willebrand factor strings puzzle.

Authors:  Karen De Ceunynck; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  Blood       Date:  2012-10-23       Impact factor: 22.113

6.  Increased claudin-3, -4 and -18 levels in bronchoalveolar lavage fluid reflect severity of acute lung injury.

Authors:  Wenting Jin; Linyi Rong; Yinkun Liu; Yuanlin Song; Yan Li; Jue Pan
Journal:  Respirology       Date:  2013-05       Impact factor: 6.424

7.  Health-related quality of life in Moroccan patients with rheumatoid arthritis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2012-08-18       Impact factor: 2.980

Review 8.  Aryl hydrocarbon receptor and experimental autoimmune arthritis.

Authors:  Nam Trung Nguyen; Taisuke Nakahama; Tadamitsu Kishimoto
Journal:  Semin Immunopathol       Date:  2013-08-27       Impact factor: 9.623

9.  A new methodology to associate SNPs with human diseases according to their pathway related context.

Authors:  Burcu Bakir-Gungor; Osman Ugur Sezerman
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

10.  Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.

Authors:  Lodewijk de Groot; Helmy Hinkema; Johanna Westra; Andries J Smit; Cees G M Kallenberg; Marc Bijl; Marcel D Posthumus
Journal:  Arthritis Res Ther       Date:  2011-12-14       Impact factor: 5.156

View more
  4 in total

1.  Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity.

Authors:  Massoud Saghafi; Mandana Khodashahi; Nayyereh Saadati; Azita Azarian; Zahra Rezaieyazdi; Maryam Salehi; Maryam Sahebari
Journal:  Electron Physician       Date:  2017-12-25

2.  Investigating the molecular control of deer antler extract on articular cartilage.

Authors:  Baojin Yao; Zhenwei Zhou; Mei Zhang; Xiangyang Leng; Daqing Zhao
Journal:  J Orthop Surg Res       Date:  2021-01-06       Impact factor: 2.359

3.  The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis.

Authors:  Manli Na; Zhicheng Hu; Majd Mohammad; Mariana do Nascimento Stroparo; Abukar Ali; Ying Fei; Anders Jarneborn; Peter Verhamme; Olaf Schneewind; Dominique Missiakas; Tao Jin
Journal:  mBio       Date:  2020-11-17       Impact factor: 7.867

4.  A New Explanation of Inflammation in Rheumatoid Arthritis Patients With Respect to Claudin-5, Matrix Metalloproteinase-9, and Neuroserpin.

Authors:  Sevil Arabacı Tamer; Gönül Gürol; İbrahim Tekeoğlu; Halil Harman; İhsan Hakkı Çiftçi
Journal:  Arch Rheumatol       Date:  2016-08-01       Impact factor: 1.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.